← Product Code [FZP](/submissions/SU/subpart-e%E2%80%94surgical-devices/FZP) · K032896

# ANSON REFIX VASCULAR AND TISSUE CLIP, MODELS GF-04-01 AND GF-04-02 (K032896)

_Anson Medical , Ltd. · FZP · Mar 17, 2004 · General, Plastic Surgery · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/FZP/K032896

## Device Facts

- **Applicant:** Anson Medical , Ltd.
- **Product Code:** [FZP](/submissions/SU/subpart-e%E2%80%94surgical-devices/FZP.md)
- **Decision Date:** Mar 17, 2004
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 878.4300
- **Device Class:** Class 2
- **Review Panel:** General, Plastic Surgery
- **Attributes:** Therapeutic

## Intended Use

The Anson Refix tissuc and vascular clip is intended: - To assist in the creation of anastomoses in blood vessels, grafts, . and, - For the surgical approximation of tissue to tissue, or tissue to . woven graft material for general and vascular surgery.

## Device Story

Refix Clip is an implantable surgical device consisting of a single monofilament Nitinol wire sharpened at both ends; arms are curved like a bow and separated by a central wire loop. Used by surgeons in general and vascular surgery to assist in creating anastomoses in blood vessels/grafts and for approximating tissue to tissue or tissue to woven graft material. Device includes an implantable clip and a delivery system. Operates as a mechanical fastener to secure tissues or grafts during surgical procedures.

## Clinical Evidence

Bench testing only. No clinical data provided. Biocompatibility assessed per ISO 10993-1.

## Technological Characteristics

Implantable clip and delivery system. Material: Nitinol monofilament wire. Design: Bow-shaped arms with central wire loop, sharpened ends. Biocompatibility: ISO 10993-1 compliant. Mechanical fastening principle.

## Regulatory Identification

An implantable clip is a clip-like device intended to connect internal tissues to aid healing. It is not absorbable.

## Predicate Devices

- Coalescent Surgical U-Clip ([K012317](/device/K012317.md), [K994160](/device/K994160.md) and [K971588](/device/K971588.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

K032896 page 1/2

MAR 1 7 2004

## 510(k) Summary

General Information

| Classification | Class II                                                                                     |
|----------------|----------------------------------------------------------------------------------------------|
| Trade Name     | Refix Clip                                                                                   |
| Manufacturer   | Anson Medical<br>67 Milton Park,<br>ABINGDON,<br>Oxfordshire,<br>United Kingdom.<br>OX14 4RX |
| Contact        | Ian Quirk<br>Commercial Clinical and Regulatory Affairs<br>Manager                           |

### Intended Use

The Anson Refix tissuc and vascular clip is intended:

- To assist in the creation of anastomoses in blood vessels, grafts, . and,
- For the surgical approximation of tissue to tissue, or tissue to . woven graft material for general and vascular surgery.

### Predicate Devices

The predicate device for the Refix™ device is the Coalescent Surgical U-Clip (K012317, K994160 and K971588). The Coalescent U Clip is classified as an Implantable Clip and Delivery System per 21CFR878.4300 and 21CFR878.4800.

### Device Description

The Refix tissue and vascular clip consists of an implantable clip and a delivery system. The Anson Refix Clip is comprised of a single monofilament, Nitinol wire, which is sharpened at both ends. The arms of the device are curved as in a bow and are separated via a loop of wire in the center.

{1}------------------------------------------------

K032896 Page 2/2

### Materials

All materials used in the manufacture of the Anson Refix Clip are suitable for All matchals about in the main and in numerous previously cleared products. tills use and nave been assume with ISO 10993-1 to ensure appropriate biocompatibility of all materials.

#### Testing

Appropriate product testing was conducted to evaluate conformance to riproprise specification and substantial equivalence to predicate devices.

### Summary of Substantial Equivalence

The Anson Refix Clip is equivalent to the predicate products. The indications for use, basic overall function, and materials used are substantially equivalent.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a stylized eagle with three wing feathers and a tail feather. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circle around the eagle.

MAR 1 7 2004

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Ian H.Quirk Commercial Clinical and Regulatory Affairs Manager Anson Medical Ltd. 67 Milton Park Nr. Abingdon Oxon, OX14 4RX

Re: K032896

Trade/Device Name: Anson Refix Clip Regulation Number: 21 CFR 878.4300 Regulation Name: Implantable Clip Regulatory Class: II Product Code: FZP Dated: February 2, 2004 Received: February 5, 2004

Dear Mr. Quirk:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or 10 devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination docs not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2 - Mr. Ian H.Quirk

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Miriam C. Provost

fol Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

# Indications for Use

510(k) Number (if known): K032896

Device Name: Anson Refix Clip

Indications For Use:

The Anson Refix tissue and vascular clip is intended:

- To assist in the creation of anastomoses in blood vessels, grafts, and, .
- For the surgical approximation of tissue to tissue, or tissue to woven graft . material for general and vascular surgery.

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Mìriam C. Provost

(Division Sign-Off) Division of General, Restorative, and Neurological Devices

Page 1 of 1

510(k) Number_KG32896_

---

**Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/FZP/K032896](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/FZP/K032896)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com